Ketryx Launches First-of-Its-Kind Validated AI Conference for Regulated Industries

Ketryx announces the Validated AI Conference, a new industry event for professionals building AI in regulated environments, offering practical frameworks for compliance and innovation.

Dallas Metrowire Staff
Technology
Ketryx Launches First-of-Its-Kind Validated AI Conference for Regulated Industries

Ketryx, the AI-native compliance platform, has announced the details of its inaugural Validated AI Conference, a first-of-its-kind event designed for engineers, quality and regulatory leaders, and AI professionals who are actively building AI systems in regulated environments. The conference will address the unique challenges of shipping AI products that must pass regulatory scrutiny, a growing concern as AI adoption accelerates in industries such as healthcare, medical devices, and pharmaceuticals.

The conference will take place on Thursday, April 9, at The Engine by MIT in Cambridge, Massachusetts, with a virtual attendance option available for remote participants. The event is built to unite professionals who are navigating the intersection of AI innovation and regulatory compliance, providing practical frameworks for compliance and innovation. Attendees will gain insights into how to leverage AI while meeting stringent regulatory requirements, a critical need as regulatory bodies increasingly focus on AI governance.

Ketryx, trusted by four of the world's top five medical device manufacturers, transforms the product lifecycle of life science teams to deliver safer products faster. Its AI-native compliance platform overlays existing tools to automate documentation, create traceability, and accelerate release cycles without disrupting existing workflows. The company's AI Agents cut manual work by 90 percent and close compliance gaps, elevating speed and quality across the entire product lifecycle. For more information about Ketryx, visit www.ketryx.com.

The Validated AI Conference comes at a pivotal time when regulators worldwide are intensifying scrutiny on AI systems. The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have issued guidance on AI in medical devices, emphasizing the need for validation and transparency. This event provides a platform for industry professionals to share best practices and learn from peers who have successfully navigated these challenges. By focusing on validated AI, the conference underscores the importance of building trustworthy AI systems that can withstand regulatory review.

Ketryx's announcement highlights the growing demand for specialized events that bridge the gap between AI innovation and compliance. As AI becomes more embedded in regulated products, the ability to demonstrate compliance will be a key differentiator for companies. The conference aims to equip attendees with the knowledge and tools to accelerate their AI initiatives while maintaining the highest standards of safety and efficacy.

Blockchain Registration

QR Code for Blockchain Registration